Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations
about
Polypharmacology in Precision Oncology: Current Applications and Future ProspectsBeyond Cisplatin - ISEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).Circulating Biomarkers in Bladder Cancer.New discoveries in the molecular landscape of bladder cancer.National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.Emerging drugs for urothelial (bladder) cancer.Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches.Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer.Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer.Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors.Emerging first line treatment options for bladder cancer: a review of phase II and III therapies in the pipeline.Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.Intratumoral Heterogeneity of ERBB2 Amplification and HER2 Expression in Micropapillary Urothelial Carcinoma.Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers.Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical TrialApatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature reviewSystemic Drug-induced Chronic Paronychia and Periungual Pyogenic Granuloma
P2860
Q30846907-8AE1D32C-BC41-4A50-BCB3-988D5F0E72E4Q37144769-7691AE01-4CFC-42ED-9B83-305F84E4A062Q37475193-17C5247E-8635-4394-811D-0F2EF9916F8EQ37530401-DFD817EC-B8B7-40C3-9238-633164CF919AQ37578747-AAA46838-5AEA-4C0E-9BEC-82A1C0EDE364Q37736758-CC9D3175-94B1-4921-9BF2-1F05B6AA6840Q38677414-D85281B0-E1D6-4167-9884-1344B077FAFAQ38810603-DF8EA8CF-FD69-4BD9-81D7-B0F31F5F9818Q39428933-D3E846FA-5C87-4BC8-A301-79939A927003Q40979460-87497B02-F1C2-4919-B508-A439FD3AB1D3Q47142673-C803EEB6-95CC-4D25-863E-67889D391DF1Q47406496-D5C87647-BE38-40CF-AE4D-4B13505D8FB8Q48234912-A9F4BB12-948C-4C48-BF6A-58B10ACD7B63Q49728493-A9FD9EEF-02BC-41DD-8ED9-F98BDB0AB054Q49887919-9B3FE871-CDE2-4485-B17C-3B9B4B554852Q49954597-EF0193A8-0A8C-482E-934A-BE0E05B5BE40Q50064748-1A2078E4-09C3-406F-B576-6BE7D903A7D9Q52618828-BCF56DB1-2E81-4DD0-B4B8-0853A796380CQ52668202-58F8CC3B-ECC4-443B-BB48-67642E4C5927Q56379383-D958DA8B-939F-40A1-B32A-3C1DD8CE1ADEQ58739900-172C0E1D-EB57-450A-8166-742D88691937Q58774943-05A5BE73-0040-4E63-A833-46B1AC047AD3
P2860
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Afatinib Activity in Platinum- ...... Patients With ERBB Alterations
@en
Afatinib Activity in Platinum- ...... atients With ERBB Alterations.
@nl
type
label
Afatinib Activity in Platinum- ...... Patients With ERBB Alterations
@en
Afatinib Activity in Platinum- ...... atients With ERBB Alterations.
@nl
prefLabel
Afatinib Activity in Platinum- ...... Patients With ERBB Alterations
@en
Afatinib Activity in Platinum- ...... atients With ERBB Alterations.
@nl
P2093
P2860
P356
P1476
Afatinib Activity in Platinum- ...... Patients With ERBB Alterations
@en
P2093
Alexa Campanile
Carrie A Fitzpatrick
James L Wade
Kai Lee Yap
Noura J Choudhury
Peter H O'Donnell
Tatjana Antic
Theodore Karrison
Walter M Stadler
Yusuke Nakamura
P2860
P304
P356
10.1200/JCO.2015.66.3047
P407
P577
2016-04-04T00:00:00Z